IL-17 is a therapeutic target for intestinal polyposis driven by mutations in the tumor suppressor LKB1.

Exhausted T cells (TEX) in cancer and chronic viral infections undergo metabolic and epigenetic remodeling, impairing their protective capabilities. However, the impact of nutrient metabolism on epige...